News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Ocean Sunfish Could Offer Clues to the “Rise of Slime”
Ashley Yeager | Apr 1, 2018
A controversial hypothesis suggests that jellyfish may one day rule the oceans, and
may tell us if we are approaching a tipping point.
Oldest Known Paintings Created by Neanderthals, Not Modern Humans
Catherine Offord | Feb 26, 2018
The animal pictures and hand stencils were made in caves in Spain thousands of years before
arrived in Europe.
European Measles Cases Quadrupled in 2017
Shawna Williams | Feb 20, 2018
The increase is attributed to a drop in immunization rates.
DNA Analysis Paints New Picture of 10,000-Year-Old Briton
Shawna Williams | Feb 7, 2018
“Cheddar Man” had dark hair and blue eyes, a sequencing analysis suggests.
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Scientists’ Expectations for Brexit Mostly Grim
Catherine Offord | Sep 12, 2017
Some researchers have already been negatively affected by the U.K.’s decision to leave the European Union, though opinions on the eventual outcome remain mixed.
U.K. Lays Out Its Vision for Post-Brexit Research
Catherine Offord | Sep 7, 2017
The government’s new position paper on science and innovation after leaving the E.U. takes a positive tone, but has frustrated researchers with its lack of detail.
Brexit Will Cost U.K. Research Funding, Report Indicates
Ashley P. Taylor | May 24, 2017
Clinical medicine and biosciences are among the UK disciplines that receive the most EU funding.
Macron’s Election Win Cheered by Scientists
Ashley P. Taylor | May 8, 2017
The future French president’s goals are pro-science, yet he will need parliamentary support.
UC Berkeley Receives CRISPR Patent in Europe
Jef Akst | Mar 24, 2017
The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.